Cerebral Ventricles is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The cerebral ventricles are a system of interconnected, fluid-filled cavities within the brain that produce, circulate, and absorb cerebrospinal fluid (CSF). The ventricular system comprises four chambers — two lateral ventricles, the third ventricle, and the fourth ventricle — connected by narrow passages and lined by ependymal cells (Sakka et al., 2011). In the adult human brain, the ventricles contain approximately 25-30 mL of CSF at any given time, while the total CSF volume (including the subarachnoid space) is approximately 125-150 mL, with the choroid plexus producing roughly 500 mL per day (Johanson et al., 2008).
[1]
Ventricular enlargement (ventriculomegaly) is one of the most consistent and readily measurable neuroimaging findings in neurodegenerative disease. In Alzheimer's disease, the rate of ventricular expansion is a sensitive biomarker of disease progression and treatment response, often outperforming hippocampal volumetry in clinical trials (Nestor et al., 2008). Disproportionate ventricular enlargement relative to cortical atrophy is the hallmark of normal pressure hydrocephalus, a treatable cause of dementia and gait disturbance (Relkin et al., 2005).
[2]
The lateral ventricles are the largest of the four ventricles, one situated within each cerebral hemisphere. Each lateral ventricle is a C-shaped cavity with a capacity of approximately 7-10 mL, consisting of five parts (Rhoton, 2002):
[3]
The lateral ventricles communicate with the third ventricle through the interventricular foramina (of Monro), located at the anterior end of the body.
[5]
The third ventricle is a narrow, slit-like midline cavity within the diencephalon, bounded by the thalamus on each side and tightly coupled to hypothalamic neuroendocrine signaling.[6][7]
The third ventricle connects to the fourth ventricle via the cerebral aqueduct (of Sylvius), a narrow channel passing through the midbrain.
The cerebral aqueduct is the narrowest part of the ventricular system (approximately 1-2 mm in diameter), passing through the midbrain between the tectum (superior colliculus and inferior colliculus) dorsally and the tegmentum ventrally. Its narrow caliber makes it the most common site of ventricular obstruction, leading to non-communicating hydrocephalus (Cinalli et al., 2004). The aqueduct is surrounded by the periaqueductal gray, a key structure for pain modulation and autonomic control.
The fourth ventricle is a tent-shaped cavity located in the posterior fossa, between the brainstem anteriorly and the cerebellum posteriorly.[4][6]:
The choroid plexus of the fourth ventricle is located in the roof, continuous with the tela choroidea.
The choroid plexus is the principal source of CSF production, responsible for approximately 60-70% of total CSF volume. It consists of a highly vascular stroma covered by a single layer of modified ependymal (choroidal epithelial) cells connected by tight junctions that form the blood-CSF barrier (Lun et al., 2015). Choroid plexus epithelial cells actively secrete CSF through a process involving:
Beyond CSF production, the choroid plexus serves as an immunological sentinel, producing cytokines, growth factors, and transport proteins. It expresses transthyretin, clusterin, and other chaperone proteins that may help clear amyloid-beta/proteins/amyloid from the CNS (Crossgrove et al., 2005).
CSF follows a well-defined circulatory route (Sakka et al., 2011):
Recent research has identified the glymphatic system as an additional CSF-mediated clearance pathway. Driven by arterial pulsation and aquaporin-4 (AQP4) water channels on astrocytic endfeet, the glymphatic system facilitates the exchange of CSF with interstitial fluid along perivascular spaces, clearing metabolic waste including [Amyloid-Beta/proteins/amyloid and tau]/proteins/tau during sleep (Iliff et al., 2012; Xie et al., 2013).
CSF serves several critical functions:
Ventricular enlargement is one of the most robust structural imaging biomarkers of Alzheimer's disease progression. Lateral ventricular volume increases at approximately 1-2 mL/year in healthy aging, but accelerates to 3-8 mL/year in AD, with the rate correlating with cognitive decline (Nestor et al., 2008; Jack et al., 2004).
Key findings include:
Choroid plexus dysfunction in AD includes reduced CSF production, impaired clearance of [Amyloid-Beta/proteins/amyloid, and increased blood-CSF barrier permeability (Serot et al., 2000).
Normal pressure hydrocephalus (NPH) is characterized by the clinical triad of gait disturbance, urinary incontinence, and cognitive impairment, combined with ventriculomegaly out of proportion to cortical atrophy (Relkin et al., 2005). NPH is a critically important diagnosis because it is one of the few reversible causes of dementia, treatable by CSF shunting.
Imaging features distinguishing NPH from neurodegenerative ventriculomegaly include:
In Huntington's disease, caudate nucleus atrophy produces characteristic enlargement of the frontal horns ("box-shaped" ventricles), visible even in presymptomatic HTT gene carriers years before clinical onset (Aylward et al., 2004). The rate of frontal horn enlargement correlates with CAG repeat length and serves as a progression biomarker in clinical trials.
frontotemporal dementia produces asymmetric ventricular enlargement reflecting the pattern of cortical atrophy:
The C9orf72 repeat expansion, the most common genetic cause of FTD and ALS, produces symmetric, predominantly posterior-predominant ventricular enlargement that may mimic normal pressure hydrocephalus (Whitwell et al., 2012).
Ventricular enlargement in Parkinson's disease is modest compared to AD and correlates primarily with cognitive decline and progression to Parkinson's Disease dementia. In Lewy body dementia, posterior-predominant ventricular enlargement reflects occipitoparietal atrophy, correlating with the visual hallucinations and visuospatial deficits characteristic of the disease (Burton et al., 2004).
In multiple sclerosis, ventricular enlargement results from periventricular white matter loss. The third ventricle width has been proposed as a simple and reliable measure of central brain atrophy that correlates with disability progression (Benedict et al., 2006).
Ventricular cerebrospinal fluid (CSF) provides direct biochemical readouts of central nervous system pathology and is a core compartment for fluid biomarker development in neurodegenerative disease.[1][8]
CSF biomarkers are most informative when interpreted as multimarker panels (amyloid, tau, glial and axonal injury markers) rather than isolated tests.
Pre-analytical handling, assay platform harmonization, and cutpoint calibration remain major determinants of cross-cohort reproducibility and real-world deployment.[8]
The ventricular system develops from the central canal of the neural tube. During early embryogenesis, the neural tube expands to form three primary brain vesicles (prosencephalon, mesencephalon, rhombencephalon), whose lumina become the ventricles. The lateral ventricles arise from the telencephalic vesicles, while the third ventricle derives from the diencephalic vesicle.
Ventricular volume increases linearly with age, approximately doubling between ages 20 and 80 (Scahill et al., 2003). This normal age-related ventriculomegaly results from gradual brain parenchymal loss (approximately 0.2-0.5% brain volume per year after age 60) and is distinct from the accelerated enlargement seen in neurodegenerative disease. Choroid plexus calcification and fibrosis increase with age, potentially reducing CSF production and waste clearance capacity.
This section links to atlas resources relevant to this brain region.
The study of Cerebral Ventricles has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.